Skip to main content
. 2022 Jun 9;9:874532. doi: 10.3389/fmolb.2022.874532

TABLE 1.

Patient demographics and clinical characteristics.

Characteristic No. of patients (%)
Total number 999 (100)
Age (years) 58 (48, 67)
T stage
 1 271 (27.1)
 2 567 (56.8)
 3 124 (12.4)
 Unknown 37 (3.7)
N stage
 0 461 (46.2)
 1 343 (34.3)
 2 108 (10.8)
 3 70 (7.0)
 Unknown 17 (1.7)
TNM stage
 I 167 (16.7)
 II 575 (57.6)
 III 240 (24.0)
 Unknown 17 (1.7)
Tumor type
 HR+/HER-2- 559 (56.0)
 HR+/HER-2+ 138 (13.8)
 HR-/HER-2+ 36 (3.6)
 TNBC 137 (13.7)
 Unknown 129 (12.9)
ER status
 Positive 208 (20.8)
 Negative 751 (75.2)
 Unknown 40 (4.0)
PR status
 Positive 299 (29.9)
 Negative 659 (66.0)
 Unknown 41 (4.1)
HER2 status
 Positive 697 (69.8)
 Negative 174 (17.4)
 Unknown 128 (12.8)